Idorsia

Idorsia is a high-potential biopharmaceutical firm based in Switzerland, a biotech powerhouse of Europe, that specializes in the discovery, development, and commercialization of new small molecules with the goal of expanding the therapeutic options horizon.

The company has more 20-year history of drug discovery, a diverse pipeline of innovative drugs, an experienced team of over 1,300 professionals, and commercial operations in Europe, Japan, and the United States. It offers a diverse and well-balanced portfolio that covers many therapeutic areas. Its portfolio includes two marketed medications as well as more than ten assets in clinical development.

At Idorsia, following the science is forefront approach. It values collaboration with academics, industrial partners, governments, non-governmental organizations (NGOs), and others in order to develop solutions to scientific issues.

Founded: 2017
Headquarters: Allschwil, Switzerland
Website: https://www.idorsia.com/